Behavior of Transaldolase (EC 2.2.1 .2) and Transketolase (EC 2.2.1.1

Total Page:16

File Type:pdf, Size:1020Kb

Behavior of Transaldolase (EC 2.2.1 .2) and Transketolase (EC 2.2.1.1 [CANCER RESEARCH 36, 3189-3197, September 1976] Behavior of Transaldolase (EC 2.2.1 .2) and Transketolase (EC 2.2.1 .1) Activities in Normal, Neoplastic, Differentiating, and Regenerating Liver Peter C. Heinrich, Harold P. Morris,1 and George Weber2 Laboratory for Experimental Oncology, Indiana University School of Medicine, Indianapolis, Indiana 46202 (P. C. H., G. W.J, and the Department of Biochemistry, Howard University College of Medicine, Washington, D. C. 20001 (H. P. M.J SUMMARY In the regenerating liver at 24 hr after partial hepatec tomy, the activity of both pentose phosphate pathway en The objective of this investigation was to throw light on zymes was in the same range as that of the sham-operated the biological behavior and metabolic regulation of hepatic controls. enzymes of the nonoxidative branch of the pentose phos In differentiation at the postnatal age of 5, 12, 23, and 32 phate pathway. The activities of transaldolase (EC 2.2.1 .2) days, hepatic transaldolase activities were 33, 44, 55, and and transketolase (EC 2.2.1 .1) were compared in biological 72%, respectively, of the activities observed in the 60-day conditions that involve modulation of gene expression such old, adult male rat. During the same period, transketolase as in starvation, in differentiation, after partial hepatectomy, activities were 18, 21, 26, and 55% of the activities observed and in a spectrum of hepatomas of different growth rates. in liver of adult rat. The enzyme activities were determined under optimal ki The demonstration of increased transaldolase activity in netic conditions by spectrophotometric methods in the hepatomas, irrespective of the degree of tumor malignancy, 100,000 x g supernatant fluids prepared from tissue ho differentiation, orgnowth rate, suggeststhatthe reprogram mogenates. ming of gene expression in malignant transformation is The kinetic properties of transaldolase and tnansketolase linked with an increase in the expression of this pentose were similar in normal liver and in rapidly growing hepa phosphate pathway enzyme. Since no similar alteration was toma 3924A. For transaldolase, apparent K,, values of 0.13 found in the differentiating or regenerating liven, the in mM (normal liven) and 0.17 mM (hepatoma) were observed creased transaldolase activity appears to be specific to the for erythrose 4-phosphate and of 0.30 to 0.35 mM for fruc neoplastic transformation. The increase in transaldolase tose 6-phosphate. The pH optima in liven and hepatoma activity in conjunction with the earlier observed increase in were at approximately 6.9 to 7.2. For the transketolase glucose-6-phosphate dehydnogenase activity should pro substrates, nibose S-phosphate and xylulose S-phosphate, vide selective advantages to the neoplastic cells. the apparent K@values were 0.3 and 0.5 mM, respectively, in both liver and hepatoma. A broad pH optimum around 7.6 INTRODUCTION was observed in both tissues. In organ distribution studies, enzyme activities were mea In neoplastic transformation and progression, there is a sured in liver, intestinal mucosa, thymus, kidney, spleen, stringent need for a supply of nibose 5-phosphate for DNA brain, adipose tissue, lung, heart, and skeletal muscle. Tak synthesis and cell proliferation. In liven, the production of ing the specific activity of liver as 100%, transaldolase activ ribose 5-phosphate may proceed through the oxidative ity was the highest in intestinal mucosa (316%) and in thy pathway, chiefly by action of glucose 6-phosphate and 6- mus (219%); it was the lowest in heart (53%) and in skeletal phosphogluconate dehydrogenases, and through the non muscle (21%). Transketolase activity was highest in kidney oxidative pathway, primarily by the action of transaldolase (155%) and lowest in heart (26%) and skeletal muscle (23%). and tnansketolase. Earlier work in this laboratory demon Starvation decreased transaldolase and tnansketolase ac strated that the activity of glucose-6-phosphate dehydro tivities in 6 days to 69 and 74%, respectively, of those of the genase was increased in all the tumors of the Morris hepa liver of the normal, fed mat.This was in the same range as toma spectrum (35). Whereas much has been learned of the the decrease in the protein concentration (66%). behavior and modulation of the glucose-6-phosphate and In the liver tumors, transaldolase activity was increased 6-phosphogluconate dehydrogenases, relatively little is 1.5- to 3.4-fold over the activities observed in normal control known of the biological chemistry of the transaldolase and rat liver. Transketolase activity showed no relationship to tnansketolase enzymes in normal and neoplastic liver (35). tumor proliferation mate. The purpose of this work was to elucidate the possible linkage of transaldolase and transketolase to metabolic I Recipient of USPHS Grant CA-10792. transformation and progression by examining the enzyme 2Recipient of USPHS Grants CA-13526 and CA-05034. To whom requests activities in liven tumors of different malignancy. To under for reprints should be addressed, at the Laboratory for Experimental Oncol ogy, Indiana University School of Medicine, Indianapolis, Ind. 46202. stand more deeply the metabolic roles of these enzymes, Received April 6, 1976; accepted June 3, 1976 transaldolase and transketolase activities were also investi SEPTEMBER1976 3189 Downloaded from cancerres.aacrjournals.org on September 24, 2021. © 1976 American Association for Cancer Research. P. Heinrich et a!. gated in conditions that involve regulation of gene expres to enythnose 4-phosphate. The formation of glycenaldehyde sion such as in differentiation, in regeneration, and during 3-phosphate was followed by measuring the decrease in long-term starvation in rat liven. absorbance of NADH at 340 nm in the presence of tniose The results showed that, in a spectrum of hepatomas of phosphate isomerase and glycerophosphate dehydnogen vastly different growth rates, transketolase activity showed ase (4). The standard assay mixture had the following com no pattern, but transaldolase activity was increased in all position: 60 mM tniethanolamine buffer, pH 7.4; 6 mM EDTA; the tumors studied. Both transaldolase and transketolase 15 mM fructose 6-phosphate; 1.0 mM enythrose 4-phos responded with a marked decrease in activity to starvation, phate; 0.24 mM f3-NADH; 3.6 @gglycerophosphate dehydno exhibited a characteristic rising pattern in differentiation, genase; and 0.4 @gtniosephosphate isomerase. The final and showed no change in the regenerating liven. It was volume was 1.0 ml. concluded that the increased transaldolase activity in the Transketolase Assay. The principle of the method was hepatomas is a transformation-linked alteration in gene the measurement of the formation of glycenaldehyde 3- expression that appears to be specific to neoplastic prolifer phosphate from xylulose S-phosphate and nibose 5-phos ation. phate as receptor aldehyde by following the oxidation of NADH at 340 nm in the presence of tniosephosphate isomer ase and glycerophosphate dehydnogenase (7). Mg2@and MATERIALS AND METHODS thiamine diphosphate were added, although they did not influence the enzymatic activity. The standard assay mix Experimental animals were kept in individual cages and tune was as follows: SOmM Tnis-HCI, pH 7.5; 5 mM MgCI2; Purina Laboratory chow and water were available ad libi 0.06 mM thiamine diphosphate; 0.24 mM NADH; 3.6 @g tum , except in starvation experiments where only water was glycerophosphate dehydrogenase, 0.4 p.g tniosephosphate provided (20). isomenase; 5.0 mM nibose 5-phosphate; and 5.0 mM xylulose Tumor-bearing and Control Animals. The hepatomas 5-phosphate. The final volume was 1.0 ml. were transplanted s.c. bilaterally in inbred strains of male Protein determinations were made by the procedure de Buffalo on ACI/N rats. Normal rats of the same strain, sex, scnibed by Lownyetal. (17). The cell counts were carried out age, and weight were killed with the tumor-beaning rats as described previously (27). under the same experimental conditions. To have a wide Expression and Evaluation of Results. Transaldolase spectrum of malignancy, we examined a number of tumor and transketolase activities were calculated as j@molesof lines, including the slowly growing 66, 47C, 8999, and 44; substrate metabolized per hr at 37°andwere expressed pen the intermediate growth rate tumors 9633 and 7794A, and g wet weight of tissue, pen mg of protein, on pen average the rapidly growing hepatomas 7777, 3924A, 3683F, and cell. Cell counts were expressed as cellularity calculated in 9618A2. The neoplasrns were harvested when they had millions of nuclei per g wet weight oftissue (27). The expeni reached a diameter of about 1.5 cm (20). mental results were subjected to statistical evaluation by Regenerating Liver. Partial hepatectomy was carried out means of the t test for small samples. Differences between by the standard procedure of Higgins and Anderson (13). means giving a probability of less than 5% were considered The remaining liven lobes were examined at 24 hr after to be significant. operation. Sham-operated animals were used as controls, as described elsewhere (20). Differentiating Liver. Pregnant Wistan rats were pun RESULTS chased from Harlan Industries, Cumbenland, Ind., and the litters were allowed to remain in the same cage with the In order to establish that linear kinetics operate in the mother for 18 days after birth; then each rat was placed in crude supernatant system used in the transaldolase and an individual cage. transketolase assays, the properties and behavior of these Effects of Starvation. Male albino Wistan rats (Harlan enzymes were compared in extracts from normal liven and Industries),190to 200 g, were used. hepatomas. Preparation of Liver and Tumor Samples. The rats were Comparison of Kinetic Properties of Transaldolase in stunned, decapitated, and exsanguinated. Livers and tu Liver and Hepatoma 3924A. Chart 1 shows the effect of moms were rapidly removed, and preparation of homoge enythrose 4-phosphate on transaldolase activity in rat liven nates and supennatant fluids was carried out as described (ACI/N strain) and in rapidly growing hepatoma 3924A (can previously (20, 33).
Recommended publications
  • Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism
    biology Article Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism Ibrahim H. Polat 1,2,3 ,Míriam Tarrado-Castellarnau 1,4 , Rohit Bharat 1, Jordi Perarnau 1 , Adrian Benito 1,5 , Roldán Cortés 1, Philippe Sabatier 2 and Marta Cascante 1,4,* 1 Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine (IBUB), Faculty of Biology, Universitat de Barcelona, Av Diagonal 643, 08028 Barcelona, Spain; [email protected] (I.H.P.); [email protected] (M.T.-C.); [email protected] (R.B.); [email protected] (J.P.); [email protected] (A.B.); [email protected] (R.C.) 2 Equipe Environnement et Prédiction de la Santé des Populations, Laboratoire TIMC (UMR 5525), CHU de Grenoble, Université Grenoble Alpes, 38700 CEDEX La Tronche, France; [email protected] 3 Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, 60590 Frankfurt, Germany 4 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), 28001 Madrid, Spain 5 Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London W12 0NN, UK * Correspondence: [email protected] Simple Summary: Cancer cells alter their metabolism to maintain their high need for energy, produce Citation: Polat, I.H.; enough macromolecules for biosynthesis, and preserve their redox status. The investigation of Tarrado-Castellarnau, M.; Bharat, R.; cancer cell-specific metabolic alterations has vital importance to identify targets to be exploited for Perarnau, J.; Benito, A.; Cortés, R.; therapeutic development. The pentose phosphate pathway (PPP) is often highly activated in tumor Sabatier, P.; Cascante, M.
    [Show full text]
  • Enzyme Characterisation and Kinetic Modelling of the Pentose Phosphate
    1 Enzyme characterisation and kinetic modelling of the pentose 2 phosphate pathway in yeast 1;2 3 Hanan L. Messiha Edward Kent 1;3;4 Naglis Malys 1;2;6 Kathleen M. Carroll 1;5 Neil Swainston 1;4 s 1;4;7;∗ t Pedro Mendes 1;4 n Kieran Smallbone i r P 1Manchester Centre for Integrative Systems Biology e r 2Faculty of Life Sciences 3 P Doctoral Training Centre in Integrative Systems Biology 4School of Computer Science 5School of Chemistry University of Manchester, M13 9PL, UK. 6School of Life Sciences, Gibbet Hill Campus, University of Warwick, Coventry, UK. 7Center for Quantitative Medicine and Department of Cell Biology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA. 4 Abstract 5 We present the quantification and kinetic characterisation of the enzymes of the pentose 6 phosphate pathway in Saccharomyces cerevisiae. The data are combined into a mathematical 7 model that describes the dynamics of this system and allows us to predict changes in metabo- 8 lite concentrations and fluxes in response to perturbations. We use the model to study the 9 response of yeast to a glucose pulse. We then combine the model with an existing glycolysis 10 model to study the effect of oxidative stress on carbohydrate metabolism. The combina- 11 tion of these two models was made possible by the standardised enzyme kinetic experiments 12 carried out in both studies. This work demonstrates the feasibility of constructing larger 13 network-scale models by merging smaller pathway-scale models. ∗To whom correspondence should be addressed at [email protected] PeerJ PrePrints | http://dx.doi.org/10.7287/peerj.preprints.146v4 | CC-BY 3.0 Open Access | received: 10 Apr 2014, published: 10 Apr 2014 1 14 Introduction 15 The pentose phosphate pathway (PPP) is a central and widely conserved metabolic pathway of car- 16 bohydrate metabolism which, in eukaryotic cells, is located in the cytoplasm (see Figure 1).
    [Show full text]
  • Lecture 7 - the Calvin Cycle and the Pentose Phosphate Pathway
    Lecture 7 - The Calvin Cycle and the Pentose Phosphate Pathway Chem 454: Regulatory Mechanisms in Biochemistry University of Wisconsin-Eau Claire 1 Introduction The Calvin cycle Text The dark reactions of photosynthesis in green plants Reduces carbon from CO2 to hexose (C6H12O6) Requires ATP for free energy and NADPH as a reducing agent. 2 2 Introduction NADH versus Text NADPH 3 3 Introduction The Pentose Phosphate Pathway Used in all organisms Glucose is oxidized and decarboxylated to produce reduced NADPH Used for the synthesis and degradation of pentoses Shares reactions with the Calvin cycle 4 4 1. The Calvin Cycle Source of carbon is CO2 Text Takes place in the stroma of the chloroplasts Comprises three stages Fixation of CO2 by ribulose 1,5-bisphosphate to form two 3-phosphoglycerate molecules Reduction of 3-phosphoglycerate to produce hexose sugars Regeneration of ribulose 1,5-bisphosphate 5 5 1. Calvin Cycle Three stages 6 6 1.1 Stage I: Fixation Incorporation of CO2 into 3-phosphoglycerate 7 7 1.1 Stage I: Fixation Rubisco: Ribulose 1,5- bisphosphate carboxylase/ oxygenase 8 8 1.1 Stage I: Fixation Active site contains a divalent metal ion 9 9 1.2 Rubisco Oxygenase Activity Rubisco also catalyzes a wasteful oxygenase reaction: 10 10 1.3 State II: Formation of Hexoses Reactions similar to those of gluconeogenesis But they take place in the chloroplasts And use NADPH instead of NADH 11 11 1.3 State III: Regeneration of Ribulose 1,5-Bisphosphosphate Involves a sequence of transketolase and aldolase reactions. 12 12 1.3 State III:
    [Show full text]
  • The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
    International Journal of Molecular Sciences Review The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance Isabella Giacomini 1, Eugenio Ragazzi 1 , Gianfranco Pasut 2 and Monica Montopoli 1,3,* 1 Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Largo Egidio Meneghetti 2, 35131 Padova, Italy; [email protected] (I.G.); [email protected] (E.R.) 2 Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131 Padova, Italy; [email protected] 3 Veneto Institute of Molecular Medicine, Via Giuseppe Orus 2, 35129 Padova, Italy * Correspondence: [email protected]; Tel.: +39-049-827-5090 Received: 30 December 2019; Accepted: 29 January 2020; Published: 31 January 2020 Abstract: Cisplatin is the first-line treatment for different types of solid tumors, such as ovarian, testicular, bladder, cervical, head and neck, lung, and esophageal cancers. The main problem related to its clinical use is the onset of drug resistance. In the last decades, among the studied molecular mechanisms of cisplatin resistance, metabolic reprogramming has emerged as a possible one. This review focuses on the pentose phosphate pathway (PPP) playing a pivotal role in maintaining the high cell proliferation rate and representing an advantage for cancer cells. In particular, the oxidative branch of PPP plays a role in oxidative stress and seems to be involved in cisplatin resistance. In light of these considerations, it has been demonstrated that overexpression and higher enzymatic activity of different enzymes of both oxidative and non-oxidative branches (such as glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and transketolase) increase cisplatin resistance, and their silencing or combined treatment with cisplatin could restore cisplatin sensitivity.
    [Show full text]
  • RESPIRATION Pentose Phosphate Pathway Or Hexose Monophosphate Pathway
    RESPIRATION Pentose Phosphate Pathway or Hexose Monophosphate Pathway Pentose phosphate pathway or hexose monophosphate pathway (HMP pathway) is the other common pathway to break down glucose to pyruvate and operates in both aerobic and anaerobic conditions. This pathway produces NADPH, which carries chemical energy in the form of reducing power and is used almost universally as the reductant in anabolic (energy utilization) pathways (e.g., fatty acid biosynthesis, cholesterol biosynthesis, nucleotide biosynthesis) and detoxification pathways (e.g., reduction of oxidized glutathione, cytochrome P450 monooxygenases). Also, the pentose phosphate pathway generates pentose sugar ribose and its derivatives, which are necessary for the biosynthesis of nucleic acids (DNA and RNA) as well as ATP, NADH, FAD, and coenzyme A. In this way, though the pentose phosphate pathway may be a source of energy in many microorganisms, it is more often of greater importance in various biosynthetic pathways. Pentose phosphate pathway consists of two phases: the oxidative phase and the non-oxidative phase. Oxidative Phase: The oxidative phase of the pentose phosphate pathway initiates with the conversion of glucose 6- phosphate to 6-Phosphogluconate. NADP+ is the electron acceptor yielding NADPH during this reaction. 6-Phosphogluconate, a six-carbon sugar, is then oxidativelydecarboxylated to yield ribulose 5-phosphate, a five-carbon sugar. NADP+ is again the electron acceptor yielding NADPH. In the final step of oxidative phase, there is isomerisation of ribulose 5-phosphatc to ribose 5- phosphate by phosphopentose isomerase and the conversion of ribulose 5-phosphate into its epimerxylulose 5-phosphate by phosphopentose epimerase for the transketolase reaction in non- oxidative phase.
    [Show full text]
  • Transaldolase B of Escherichia Coli K-12: Cloning of Its Gene, Talb, and Characterization of the Enzyme from Recombinant Strains
    JOURNAL OF BACTERIOLOGY, Oct. 1995, p. 5930–5936 Vol. 177, No. 20 0021-9193/95/$04.0010 Copyright q 1995, American Society for Microbiology Transaldolase B of Escherichia coli K-12: Cloning of Its Gene, talB, and Characterization of the Enzyme from Recombinant Strains GEORG A. SPRENGER,* ULRICH SCHO¨ RKEN, GERDA SPRENGER, AND HERMANN SAHM Institut fu¨r Biotechnologie 1, Forschungszentrum Ju¨lich GmbH, D-52425 Ju¨lich, Germany Received 7 June 1995/Accepted 7 August 1995 A previously recognized open reading frame (T. Yura, H. Mori, H. Nagai, T. Nagata, A. Ishihama, N. Fujita, K. Isono, K. Mizobuchi, and A. Nakata, Nucleic Acids Res. 20:3305–3308) from the 0.2-min region of the Escherichia coli K-12 chromosome is shown to encode a functional transaldolase activity. After cloning of the gene onto high-copy-number vectors, transaldolase B (D-sedoheptulose-7-phosphate:D-glyceraldehyde-3-phos- phate dihydroxyacetone transferase; EC 2.2.1.2) was overexpressed up to 12.7 U mg of protein21 compared with less than 0.1 U mg of protein21 in wild-type homogenates. The enzyme was purified from recombinant E. coli K-12 cells by successive ammonium sulfate precipitations (45 to 80% and subsequently 55 to 70%) and two anion-exchange chromatography steps (Q-Sepharose FF, Fractogel EMD-DEAE tentacle column; yield, 130 mg of protein from 12 g of cell wet weight) and afforded an apparently homogeneous protein band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with a subunit size of 35,000 6 1,000 Da. As the enzyme had a molecular mass of 70,000 Da by gel filtration, transaldolase B is likely to form a homodimer.
    [Show full text]
  • Chemoenzymatic Synthesis of Novel, Structurally Diverse Compounds
    Chemoenzymatic synthesis of novel, structurally diverse compounds A Thesis Submitted for the Degree of Doctor of Philosophy to the University of London Lydia G Coward Department of Biochemical Engineering University College London 1 I, Lydia Grace Coward confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 For my fantastic family. 3 Abstract The use of Diels Alder cycloaddition chemistries to access a diverse range of useful cyclic structures is well established throughout literature. However, the value of the product may be enhanced further still by linking this reaction with subsequent (biocatalytic) steps to create novel, structurally demanding, optically pure compounds. This project investigates the linking of Diels Alder (DA) chemistry to the enzyme, transketolase (TK) as a model integration pathway of a chemical syntheses and a biological transformation. The two-step process aims to provide a framework to synthesise small structurally diverse compounds with high enantiomeric excess. The demand for optically pure compounds is becoming a necessity due to the adverse affects frequently introduced by racemic compounds and the cost implications of the material possessing often only 50% active compound. Recombinant wild type Eschericha coli transketolase (EC 2.2.1.1) (WT-TK) was overexpressed in E. coli for the biocatalytic step of this two step synthesis. A substrate walking approach whereby a range of sequentially linked cyclic aldehydes, were applied to wild type transketolase and potential activity detected. Transketolase mutants, previously constructed based on information derived from the structural position within the active site of the dimeric enzyme were subsequently screened for activity with the cycloadduct of the Diels Alder reaction as aldehyde acceptor substrate for TK.
    [Show full text]
  • PENTOSE PHOSPHATE PATHWAY — Restricted for Students Enrolled in MCB102, UC Berkeley, Spring 2008 ONLY
    Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY Bryan Krantz: University of California, Berkeley MCB 102, Spring 2008, Metabolism Lecture 5 Reading: Ch. 14 of Principles of Biochemistry, “Glycolysis, Gluconeogenesis, & Pentose Phosphate Pathway.” PENTOSE PHOSPHATE PATHWAY This pathway produces ribose from glucose, and it also generates 2 NADPH. Two Phases: [1] Oxidative Phase & [2] Non-oxidative Phase + + Glucose 6-Phosphate + 2 NADP + H2O Ribose 5-Phosphate + 2 NADPH + CO2 + 2H ● What are pentoses? Why do we need them? ◦ DNA & RNA ◦ Cofactors in enzymes ● Where do we get them? Diet and from glucose (and other sugars) via the Pentose Phosphate Pathway. ● Is the Pentose Phosphate Pathway just about making ribose sugars from glucose? (1) Important for biosynthetic pathways using NADPH, and (2) a high cytosolic reducing potential from NADPH is sometimes required to advert oxidative damage by radicals, e.g., ● - ● O2 and H—O Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY Two Phases of the Pentose Pathway Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY NADPH vs. NADH Metabolism Lecture 5 — PENTOSE PHOSPHATE PATHWAY — Restricted for students enrolled in MCB102, UC Berkeley, Spring 2008 ONLY Oxidative Phase: Glucose-6-P Ribose-5-P Glucose 6-phosphate dehydrogenase. First enzymatic step in oxidative phase, converting NADP+ to NADPH. Glucose 6-phosphate + NADP+ 6-Phosphoglucono-δ-lactone + NADPH + H+ Mechanism. Oxidation reaction of C1 position. Hydride transfer to the NADP+, forming a lactone, which is an intra-molecular ester.
    [Show full text]
  • Synthesis and Cell Survival Under Stress Conditions . the PPP
    Pentose phosphate pathway Significance of Pentose Phosphate Pathway To generate reducing equivalents, in the form of NADPH, which is needed for fatty acid synthesis and cell survival under stress conditions . To provide the cell with ribose-5-phosphate (R5P) for the synthesis of the nucleotides and nucleic acids. No ATP is generated in this pathway. So glucose can be metabolized through this pathway even when energy requirement is low. Location of the pathway • The enzymes are located in the cytosol. The tissues such as liver, adipose tissue, adrenal gland, erythrocytes, testes & lactating mammary gland, are highly active in the oxidative phase of HMP shunt. Rapidly dividing cells have a high activity of the non-oxidative phase. *It is called the pentose phosphate shunt because the pathway allows for carbon atoms from glucose 6-phosphate to take a shunt before they proceed down the glycolytic pathway. The PPP comprises two irreversible oxidative reactions followed by a series of reversible interconversions. The PPP is thus divided into two biochemical branches: An oxidative and a non-oxidative branch. The oxidative branch converts glucose 6-phosphate (G6P) into ribulose-5-phosphate (Ru5P), CO2 and NADPH. NADPH is vital to maintain the reduction-oxidation (redox) balance under stress conditions and allows cells to proliferate rapidly. The non-oxidative branch yields the glycolytic intermediates fructose 6-phosphate (F6P), glyceraldehyde 3-phosphate (G3P) and sedoheptulose sugars, resulting in the production of sugar phosphate precursors for amino acid synthesis and ribose-5-phosphate (R5P), which is essential for nucleic acid synthesis. Oxidative Phase of the Pentose Phosphate Pathway Glucose 6-phosphate is oxidized to 6-phosphoglucono-δ-lactone to generate one molecule of NADPH.
    [Show full text]
  • Pentose Phosphate Pathway
    Metabolism: Pentose phosphate pathway Hand-out for the CBT – version May 2012 1. Which of the following compounds are products of the pentose phosphate pathway? o NADPH o glycerate 3-phosphate o CO2 o ribulose 5-phosphate o sedoheptulose 7-phosphate 2. The first four reactions of the pentose phosphate pathway form the oxidative phase. The following questions deal with these reactions. A. What are the names of these compounds? B. During which reactions are CO2 and NADPH produced? C. What reaction is catalyzed by phosphopentose isomerase? D. Which compound can be a group acceptor in the transketolase reaction? 3. The following questions are about glucose 6-phosphate dehydrogenase. A. Is 6-phosphogluconate one of its products? B. Is it regulated by the availability of NAD+? C. Does is contain thiamine pyrophosphate as a cofactor? D. A committed step is an effectively irreversible enzymatic reaction that occurs in metabolic reactions during the biosynthesis of some molecules. Does glucose 6-phosphate dehydrogenase catalyse the committed step in the pentose phosphate pathway? E. Is it important in the metabolism of glutathione in erythrocytes? 4. The pentose phosphate pathway has a nonoxidative branch. What reactions does it include? 5. The liver synthesizes fatty acids and lipids for export to other tissues. What activity do you expect the pentose phosphate pathway to have in the liver? o Low, because this synthesis needs ATP and pentoses as a source o Low, because no reductive force is needed o High, because this is reductive biosynthesis o High, because the conversion of sugars is required 6. A.
    [Show full text]
  • Pentose Phosphate Pathway Biochemistry, Metabolism and Inherited Defects
    Pentose phosphate pathway biochemistry, metabolism and inherited defects Amsterdam 2008 Mirjam M.C. Wamelink The research described in this thesis was carried out at the Department of Clinical Chemistry, Metabolic Unit, VU University Medical Center, Amsterdam, The Netherlands. The publication of this thesis was financially supported by: Department of Clinical Chemistry, VU University Medical Center Amsterdam E.C. Noyons Stichting ter bevordering van de Klinische Chemie in Nederland J.E. Jurriaanse Stichting te Rotterdam Printed by: Printpartners Ipskamp BV, Enschede ISBN: 978-90-9023415-1 Cover: Representation of a pathway of sugar Copyright Mirjam Wamelink, Amsterdam, The Netherlands, 2008 2 VRIJE UNIVERSITEIT Pentose phosphate pathway biochemistry, metabolism and inherited defects ACADEMISCH PROEFSCHRIFT ter verkrijging van de graad Doctor aan de Vrije Universiteit Amsterdam, op gezag van de rector magnificus prof.dr. L.M. Bouter, in het openbaar te verdedigen ten overstaan van de promotiecommissie van de faculteit der Geneeskunde op donderdag 11 december 2008 om 13.45 uur in de aula van de universiteit, De Boelelaan 1105 door Mirjam Maria Catharina Wamelink geboren te Alkmaar 3 promotor: prof.dr.ir. C.A.J.M. Jakobs copromotor: dr. E.A. Struijs 4 Abbreviations 6PGD 6-phosphogluconate dehydrogenase ADP adenosine diphosphate ATP adenosine triphosphate CSF cerebrospinal fluid DHAP dihydroxyacetone phosphate G6PD glucose-6-phosphate dehydrogenase GA glyceraldehyde GAPDH glyceraldehyde-3-phosphate dehydrogenase GSG oxidized glutathione
    [Show full text]
  • Novel Thermostable Enzymes for Industrial Biotechnology
    Novel thermostable enzymes for industrial biotechnology Project acronym: THERMOGENE Project no: EIB.12.012 Name Prof Jennifer Littlechild ERA-IB-2 final conference, Berlin, 16./17.02.2016 Project partners Co-ordinator – Prof Jennifer Littlechild (Exeter, UK) Prof Peter Schoenheit (Kiel, Germany) Prof Nils-Kåre Birkeland ( Bergen, Norway) Molecular Technologies Ltd. SME ( Moscow, Russia) Industrial Advisor Dr Roland Wohlgemuth, Sigma–Aldrich/Merck. Budget Exeter- 326,260 (80% funding), 362,000 (Kiel), 296,602 (Bergen), 306,378 (50% funding) TOTAL 1,291,240 euros Project THERMOGENE ERA-IB-2 Final conference, Berlin, 16./17.02.2016 www.era-ib.net Industrial Relevance of Project • The project aims to "Improve enzyme systems for new and more efficient bioprocesses". • Use of enzymes for chemical processes is a route to lower energy consumption and reduced waste generation. In addition the selectivity of enzymatic processes reduces raw material costs and the safety issues surrounding the production of wasteful bi-products. Optimised enzyme production will lead to economically viable and cost effective, sustainable production. • New thermostable transferase enzymes with enhanced performance and/or novel functionalities can provide savings in time, money and energy for industrial processes in the areas of high value chemical production and other "white" biotechnology applications. Project THERMOGENE ERA-IB-2 Final conference, Berlin, 16./17.02.2016 www.era-ib.net Introduction Objective -Identify and characterizise different classes of thermostable transferase enzymes – transaminases, transketolases, prenyl transferases and hydroxymethyl transferases with applications in biotechnology. General Project Approach-The project uses natural thermophilic resources to isolate and enrich microorganisms with the desired enzymatic activities.
    [Show full text]